외래 주입 센터 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Ambulatory Infusion Centers Market - Scope of Report

TMR's report on the global ambulatory infusion centers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global ambulatory infusion centers market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ambulatory infusion centers market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ambulatory infusion centers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ambulatory infusion centers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ambulatory infusion centers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ambulatory infusion centers market.

The report delves into the competitive landscape of the global ambulatory infusion centers market. Key players operating in the global ambulatory infusion centers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ambulatory infusion centers market profiled in this report.

Key Questions Answered in Global ambulatory infusion centers Market Report:

• What is the sales/revenue generated by ambulatory infusion centers across all regions during the forecast period?
• What are the opportunities in the global ambulatory infusion centers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Ambulatory Infusion Centers Market - Research Objectives and Research Approach

The comprehensive report on the global ambulatory infusion centers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ambulatory infusion centers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ambulatory infusion centers market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ambulatory Infusion Centers Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Ambulatory Infusion Centers Market Analysis and Forecast, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Key Industry Events
• 5.2. PESTEL Analysis
• 5.3. Regulatory Scenario by Key Countries/Region
• 5.4. PORTER's Five Forces Analysis
• 5.5. Technological Advancements
• 5.6. Unmet Needs of the Market
• 5.7. Healthcare Spending's by Country

6. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Type of Center

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Type of Center, 2020-2035
  • 6.3.1. Hospital-based Infusion Centers
  • 6.3.2. Physician-based Infusion Centers
  • 6.3.3. Independent Infusion Centers
• 6.4. Market Attractiveness Analysis, by Type of Center

7. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Therapy Type

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 7.3.1. Antibiotics
  • 7.3.2. Blood Products
  • 7.3.3. Nutritional Products
  • 7.3.4. Immunosuppressants
  • 7.3.5. Immunostimulants
  • 7.3.6. Monoclonal Antibodies
  • 7.3.7. Immunoglobulin Therapy
  • 7.3.8. Others
• 7.4. Market Attractiveness Analysis, by Therapy Type

8. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Disease Specialties

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Disease Specialties, 2020-2035
  • 8.3.1. Oncology
  • 8.3.2. Pulmonology
  • 8.3.3. Neurology
  • 8.3.4. Gastrointestinal
  • 8.3.5. Immunology
  • 8.3.6. Cardiology
  • 8.3.7. Others
• 8.4. Market Attractiveness Analysis, by Disease Specialties

9. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020-2035
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Ambulatory Infusion Centers Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Type of Center, 2020-2035
  • 10.2.1. Hospital-based Infusion Centers
  • 10.2.2. Physician-based Infusion Centers
  • 10.2.3. Independent Infusion Centers
• 10.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 10.3.1. Antibiotics
  • 10.3.2. Blood Products
  • 10.3.3. Nutritional Products
  • 10.3.4. Immunosuppressants
  • 10.3.5. Immunostimulants
  • 10.3.6. Monoclonal Antibodies
  • 10.3.7. Immunoglobulin Therapy
  • 10.3.8. Others
• 10.4. Market Value Forecast, by Disease Specialties, 2020-2035
  • 10.4.1. Oncology
  • 10.4.2. Pulmonology
  • 10.4.3. Neurology
  • 10.4.4. Gastrointestinal
  • 10.4.5. Immunology
  • 10.4.6. Cardiology
  • 10.4.7. Others
• 10.5. Market Value Forecast, by Country, 2020-2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Type of Center
  • 10.6.2. By Therapy Type
  • 10.6.3. By Disease Specialties
  • 10.6.4. By Country

11. Europe Ambulatory Infusion Centers Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Type of Center, 2020-2035
  • 11.2.1. Hospital-based Infusion Centers
  • 11.2.2. Physician-based Infusion Centers
  • 11.2.3. Independent Infusion Centers
• 11.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 11.3.1. Antibiotics
  • 11.3.2. Blood Products
  • 11.3.3. Nutritional Products
  • 11.3.4. Immunosuppressants
  • 11.3.5. Immunostimulants
  • 11.3.6. Monoclonal Antibodies
  • 11.3.7. Immunoglobulin Therapy
  • 11.3.8. Others
• 11.4. Market Value Forecast, by Disease Specialties, 2020-2035
  • 11.4.1. Oncology
  • 11.4.2. Pulmonology
  • 11.4.3. Neurology
  • 11.4.4. Gastrointestinal
  • 11.4.5. Immunology
  • 11.4.6. Cardiology
  • 11.4.7. Others
• 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 11.5.1. Germany
  • 11.5.2. UK
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Type of Center
  • 11.6.2. By Therapy Type
  • 11.6.3. By Disease Specialties
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Ambulatory Infusion Centers Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Type of Center, 2020-2035
  • 12.2.1. Hospital-based Infusion Centers
  • 12.2.2. Physician-based Infusion Centers
  • 12.2.3. Independent Infusion Centers
• 12.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 12.3.1. Antibiotics
  • 12.3.2. Blood Products
  • 12.3.3. Nutritional Products
  • 12.3.4. Immunosuppressants
  • 12.3.5. Immunostimulants
  • 12.3.6. Monoclonal Antibodies
  • 12.3.7. Immunoglobulin Therapy
  • 12.3.8. Others
• 12.4. Market Value Forecast, by Disease Specialties, 2020-2035
  • 12.4.1. Oncology
  • 12.4.2. Pulmonology
  • 12.4.3. Neurology
  • 12.4.4. Gastrointestinal
  • 12.4.5. Immunology
  • 12.4.6. Cardiology
  • 12.4.7. Others
• 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Type of Center
  • 12.6.2. By Therapy Type
  • 12.6.3. By Disease Specialties
  • 12.6.4. By Country/Sub-region

13. Latin America Ambulatory Infusion Centers Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Type of Center, 2020-2035
  • 13.2.1. Hospital-based Infusion Centers
  • 13.2.2. Physician-based Infusion Centers
  • 13.2.3. Independent Infusion Centers
• 13.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 13.3.1. Antibiotics
  • 13.3.2. Blood Products
  • 13.3.3. Nutritional Products
  • 13.3.4. Immunosuppressants
  • 13.3.5. Immunostimulants
  • 13.3.6. Monoclonal Antibodies
  • 13.3.7. Immunoglobulin Therapy
  • 13.3.8. Others
• 13.4. Market Value Forecast, by Disease Specialties, 2020-2035
  • 13.4.1. Oncology
  • 13.4.2. Pulmonology
  • 13.4.3. Neurology
  • 13.4.4. Gastrointestinal
  • 13.4.5. Immunology
  • 13.4.6. Cardiology
  • 13.4.7. Others
• 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Type of Center
  • 13.6.2. By Therapy Type
  • 13.6.3. By Disease Specialties
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Ambulatory Infusion Centers Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Type of Center, 2020-2035
  • 14.2.1. Hospital-based Infusion Centers
  • 14.2.2. Physician-based Infusion Centers
  • 14.2.3. Independent Infusion Centers
• 14.3. Market Value Forecast, by Therapy Type, 2020-2035
  • 14.3.1. Antibiotics
  • 14.3.2. Blood Products
  • 14.3.3. Nutritional Products
  • 14.3.4. Immunosuppressants
  • 14.3.5. Immunostimulants
  • 14.3.6. Monoclonal Antibodies
  • 14.3.7. Immunoglobulin Therapy
  • 14.3.8. Others
• 14.4. Market Value Forecast, by Disease Specialties, 2020-2035
  • 14.4.1. Oncology
  • 14.4.2. Pulmonology
  • 14.4.3. Neurology
  • 14.4.4. Gastrointestinal
  • 14.4.5. Immunology
  • 14.4.6. Cardiology
  • 14.4.7. Others
• 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Type of Center
  • 14.6.2. By Therapy Type
  • 14.6.3. By Disease Specialties
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis, by Company (2023)
• 15.3. Company Profiles
  • 15.3.1. Flexcare Infusion Centers
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Hawaii Medical Service Association
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. Pure Infusion Suites
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. National Infusion Center Association
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. TwelveStone Health Partners
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Richmond University Medical Center
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. CitusHealth
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Valley Health System
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. Cedars-Sinai
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. Arnot Health
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. PharmaScript
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. Naval Medical Center Portsmouth
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. Cheyenne Regional Medical Center
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments
  • 15.3.14. Pacific Medical Centers
    • 15.3.14.1. Company Overview
    • 15.3.14.2. Financial Overview
    • 15.3.14.3. Product Portfolio
    • 15.3.14.4. Business Strategies
    • 15.3.14.5. Recent Developments
  • 15.3.15. ChristianaCare
    • 15.3.15.1. Company Overview
    • 15.3.15.2. Financial Overview
    • 15.3.15.3. Product Portfolio
    • 15.3.15.4. Business Strategies
    • 15.3.15.5. Recent Developments